[go: up one dir, main page]

ES2244831T5 - Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica - Google Patents

Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica Download PDF

Info

Publication number
ES2244831T5
ES2244831T5 ES02794984.1T ES02794984T ES2244831T5 ES 2244831 T5 ES2244831 T5 ES 2244831T5 ES 02794984 T ES02794984 T ES 02794984T ES 2244831 T5 ES2244831 T5 ES 2244831T5
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
panthenol
hyaluronate
production
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02794984.1T
Other languages
English (en)
Other versions
ES2244831T3 (es
Inventor
Dorothea Gross
Frank Holzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ursapharm Arzneimittel GmbH
Original Assignee
Ursapharm Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7708986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2244831(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ursapharm Arzneimittel GmbH filed Critical Ursapharm Arzneimittel GmbH
Application granted granted Critical
Publication of ES2244831T3 publication Critical patent/ES2244831T3/es
Publication of ES2244831T5 publication Critical patent/ES2244831T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

imagen1
imagen2
imagen3
imagen4
imagen5
50 mg/ml de dexpantenol 1,55 mg/ml de ácido hialurónico, peso molecular: 1,5 x 106 - 3,5 x 106 Dalton 2 mg/ml de citrato de sodio Adición de disolución acuosa de ácido cítrico al 1% hasta que se alcanza pH 7,0 - pH 7,4 Adición de agua con fines de inyección hasta 1 ml
7

Claims (1)

  1. imagen1
ES02794984.1T 2001-12-12 2002-12-11 Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica Expired - Lifetime ES2244831T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10161110 2001-12-12
DE10161110A DE10161110A1 (de) 2001-12-12 2001-12-12 Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
PCT/DE2002/004527 WO2003049747A1 (de) 2001-12-12 2002-12-11 Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung

Publications (2)

Publication Number Publication Date
ES2244831T3 ES2244831T3 (es) 2005-12-16
ES2244831T5 true ES2244831T5 (es) 2016-05-10

Family

ID=7708986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02794984.1T Expired - Lifetime ES2244831T5 (es) 2001-12-12 2002-12-11 Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica

Country Status (11)

Country Link
US (1) US20050164979A1 (es)
EP (1) EP1455803B2 (es)
JP (1) JP3994089B2 (es)
CN (1) CN1310651C (es)
AT (1) ATE300306T1 (es)
AU (1) AU2002360895A1 (es)
CA (1) CA2468771C (es)
DE (2) DE10161110A1 (es)
ES (1) ES2244831T5 (es)
MX (1) MXPA04005387A (es)
WO (1) WO2003049747A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
CN1285382C (zh) * 2004-12-20 2006-11-22 凌沛学 含海藻糖和玻璃酸的鼻腔用药传递系统及其制备方法
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
KR20090053892A (ko) 2006-07-25 2009-05-28 오스모티카 코프. 점안액
WO2008068866A1 (en) * 2006-11-30 2008-06-12 Menicon Co., Ltd. Ophthalmic composition
KR100927579B1 (ko) * 2006-12-13 2009-11-23 주식회사 엘지생명과학 히아루론산 및/또는 그것의 염을 함유하는 아토피성피부염의 개선 및 치료를 위한 조성물
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
DE202008016517U1 (de) * 2008-12-12 2009-03-05 Ratiopharm Gmbh Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
US9473792B2 (en) * 2009-11-06 2016-10-18 Texas Instruments Incorporated Method and system to improve the performance of a video encoder
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
JP2013534527A (ja) * 2010-07-02 2013-09-05 ブライエン ホールデン ビジョン インスティテュート コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
CN102579478A (zh) * 2012-03-30 2012-07-18 济南康众医药科技开发有限公司 玻璃酸钠在制备药物中的应用
DE202012005650U1 (de) * 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
EP2664330A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Zusammensetzung und Arzneimittel enthaltend Omega-3-Fettsäuren sowie einen Glucosaminoglucan
CN102989045B (zh) * 2012-11-12 2015-02-25 广州共禾医药科技有限公司 生物相容的水性组合物及其用途
KR20230019268A (ko) * 2014-08-08 2023-02-08 센젠 하이타이드 바이오파마슈티컬 리미티드 액체 제형 조성물, 약제 전달 장치, 및 이들의 제조 및 사용 방법
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP3072503B1 (en) 2015-03-26 2020-09-23 D.M.G. Italia Srl Ophthalmic composition for the corneal protection
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
DE102016204472A1 (de) * 2016-03-17 2017-09-21 Ursapharm Arzneimittel Gmbh Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut
TWI609957B (zh) * 2016-06-27 2018-01-01 晶碩光學股份有限公司 用以處理隱形眼鏡之溶液及隱形眼鏡的包裝系統
JP7044467B2 (ja) * 2017-01-16 2022-03-30 ロート製薬株式会社 眼科組成物
DE202017104738U1 (de) * 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
CN107260657B (zh) * 2017-08-03 2019-02-05 广东莱恩医药研究院有限公司 一种缓释型连翘苷滴眼液及其制备方法
ES2972897T3 (es) * 2017-08-10 2024-06-17 Elixir Ilac Arastirma Ve Gelistirme A S Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio
CA3097470A1 (en) * 2018-04-18 2019-10-24 i.com medical GmbH High molecular weight hyaluronic acid for enhancing epithelial survival and reconstitution of body surfaces
CN112292135A (zh) * 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
US11576926B2 (en) * 2018-09-12 2023-02-14 Neilos S.r.l. Composition for use in the prevention and/or treatment of epistaxis
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
CN112870216A (zh) * 2021-01-29 2021-06-01 张宽才 一种药物组合物及制剂和用途
EP4039248A1 (en) * 2021-02-04 2022-08-10 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
FR3151481A1 (fr) * 2023-07-28 2025-01-31 Horus Pharma Emulsion de type huile dans eau comprenant de l’acide hyaluronique et du dexpanthenol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DE3832401A1 (de) † 1988-09-23 1990-03-29 Cassella Ag Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
IL101056A (en) † 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19517251A1 (de) * 1995-05-11 1996-11-14 Klosterfrau Mcm Vetrieb Gmbh Verwendung von Dexpanthenol zur Behandlung trockener Nasenschleimhäute
DE19541919C2 (de) † 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19549421C2 (de) † 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
AU740404B2 (en) * 1997-07-11 2001-11-01 Toray Industries, Inc. Stable pharmaceutical composition including 4,5-epoxymorphinane derivative
DE19923829A1 (de) * 1999-05-17 2000-11-23 Ulrich Kluegel Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung
CA2434242A1 (en) * 2001-01-09 2002-08-08 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye

Also Published As

Publication number Publication date
ES2244831T3 (es) 2005-12-16
JP2006501133A (ja) 2006-01-12
EP1455803A1 (de) 2004-09-15
CN1602198A (zh) 2005-03-30
EP1455803B2 (de) 2016-03-23
ATE300306T1 (de) 2005-08-15
DE50203788D1 (de) 2005-09-01
EP1455803B1 (de) 2005-07-27
CA2468771A1 (en) 2003-06-19
JP3994089B2 (ja) 2007-10-17
AU2002360895A1 (en) 2003-06-23
CA2468771C (en) 2007-01-30
US20050164979A1 (en) 2005-07-28
WO2003049747A1 (de) 2003-06-19
DE10161110A1 (de) 2003-06-26
WO2003049747A8 (de) 2003-10-02
CN1310651C (zh) 2007-04-18
MXPA04005387A (es) 2005-03-23

Similar Documents

Publication Publication Date Title
ES2244831T5 (es) Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica
TNSN98090A1 (fr) Formulations pharmaceutiques contenant du voriconazole, et procede pour leur preparation.
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
BRPI0411678A (pt) nanopartìculas de ácido hialurÈnico
CO5190689A1 (es) Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales
ATE332138T1 (de) Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
BR0214757A (pt) Formulações farmacêuticas de derivados de platina
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
BR0210293A (pt) Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral
EE05072B1 (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
ES2195344T3 (es) Composicion farmaceutica que presenta una actividad antitumoral mejorada y/o efectos secundarios reducidos, que contiene un agente antitumoral y un derivado de acido hidroximico.
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
EA200300406A1 (ru) Фармацевтическая композиция дронедарона для парентерального введения
BR0312157A (pt) Preparação lìquida que compreende oligopeptìdeos e ciclodextrina eterificada
UY27373A1 (es) Formulaciones de interferón beta-humano
BR0011845A (pt) Complexo farmacêutico
ATE233105T1 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
RU92004583A (ru) Фармацевтическая композиция и способ ее получения
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
EA200400382A1 (ru) Применение специфической дозы фондапаринукса натрия для лечения окс
GR1010769B (el) Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση